Search research articles
Contact Us
Filters
Showing results (1-10 of 51) with videos related to
Page
of 6
Sort By:
Lung Cancer (Amsterdam, Netherlands)
|
April 21, 2020
Correspondence Re: Development, validation and results from the impact of treatment evolution in non-small cell lung cancer (iTEN) model
John R Goffin
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 6, 2026
Emphysema Versus COPD in Patients Receiving Immune Checkpoint Inhibitors for NSCLC
John R Goffin, Jane Turner
Clinical Therapeutics
|
September 24, 2013
Epidermal growth factor receptor: pathway, therapies, and pipeline
John R Goffin, Kevin Zbuk
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 2, 2008
Phase II stopping rules that employ response rates and early progression
John R Goffin, Dongsheng Tu
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 20, 2006
Overstated conclusions of a pooled analysis of bevacizumab in colon cancer
John R Goffin, Joyce R Talavera
BMC Medical Research Methodology
|
December 14, 2011
Stopping rules employing response rates, time to progression, and early progressive disease for phase II oncology trials
John R Goffin, Greg R Pond
American Journal of Clinical Oncology
|
April 2, 2004
Tolerance of radiotherapy and chemotherapy in elderly patients with bladder cancer
John R Goffin, Raghu Rajan, Luis Souhami
Current Oncology (Toronto, Ont.)
|
August 27, 2025
CAPOX vs. FOLFOX for Colorectal Cancer-Real World Outcomes in Ontario, Canada
Deepro Chowdhury, Gregory R Pond, John R Goffin
BMC Medical Research Methodology
|
June 23, 2011
A comparison of a new multinomial stopping rule with stopping rules of fleming and gehan in single arm phase II cancer clinical trials
John R Goffin, Greg R Pond, Dongsheng Tu
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
June 2, 2016
Lung Cancer Screening, Cancer Treatment, and Addressing the Continuum of Health Risks Caused by Tobacco
Graham W Warren, Jamie S Ostroff, John R Goffin
Page
of 6
Search research articles
Search
Showing results (1-10 of 51) with videos related to
Sort By:
Page
of 6
Lung Cancer (Amsterdam, Netherlands)
|
April 21, 2020
Correspondence Re: Development, validation and results from the impact of treatment evolution in non-small cell lung cancer (iTEN) model
John R Goffin
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 6, 2026
Emphysema Versus COPD in Patients Receiving Immune Checkpoint Inhibitors for NSCLC
John R Goffin, Jane Turner
Clinical Therapeutics
|
September 24, 2013
Epidermal growth factor receptor: pathway, therapies, and pipeline
John R Goffin, Kevin Zbuk
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 2, 2008
Phase II stopping rules that employ response rates and early progression
John R Goffin, Dongsheng Tu
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 20, 2006
Overstated conclusions of a pooled analysis of bevacizumab in colon cancer
John R Goffin, Joyce R Talavera
BMC Medical Research Methodology
|
December 14, 2011
Stopping rules employing response rates, time to progression, and early progressive disease for phase II oncology trials
John R Goffin, Greg R Pond
American Journal of Clinical Oncology
|
April 2, 2004
Tolerance of radiotherapy and chemotherapy in elderly patients with bladder cancer
John R Goffin, Raghu Rajan, Luis Souhami
Current Oncology (Toronto, Ont.)
|
August 27, 2025
CAPOX vs. FOLFOX for Colorectal Cancer-Real World Outcomes in Ontario, Canada
Deepro Chowdhury, Gregory R Pond, John R Goffin
BMC Medical Research Methodology
|
June 23, 2011
A comparison of a new multinomial stopping rule with stopping rules of fleming and gehan in single arm phase II cancer clinical trials
John R Goffin, Greg R Pond, Dongsheng Tu
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
June 2, 2016
Lung Cancer Screening, Cancer Treatment, and Addressing the Continuum of Health Risks Caused by Tobacco
Graham W Warren, Jamie S Ostroff, John R Goffin
Page
of 6